Lipooligosaccharide (LOS) is an important virulence determinant of Neisseria gonorrhoeae. It is involved in several aspects of gonococcal infection, including immune evasion, attachment, tissue damage, and the stimulation of bactericidal antibodies (2, 9, 15, 27, 29) . Structurally, LOS is a collection of heterogeneous glycolipids that are organized in a complex, branched formation (5, 6, 12, 14) . It displays a great deal of variation, both within and between gonococcal strains. This variation is seen as a difference in the number of variably sized LOS components expressed, as well as differences in the relative concentrations of the glycolipids composing these structures (5) .
In human challenge studies involving the inoculation of volunteers with gonococci expressing a 3.6-kDa LOS (which reacts with monoclonal antibody [MAb] 2-1-L8), isolates examined after infection expressed LOSs of 4.8 kDa (which reacts with MAb 1B2) and larger (see Fig. 1 for LOS structures) (23) . The presence of larger LOS molecules suggested that either a phase shift had occurred in vivo or a preexisting variant in the inoculum was responsible for causing disease. Since we (25) had previously identified a genetic locus, now called lsi-2, that could mediate this type of shift, we were interested in cloning this gene in order to better define the genetic basis for this variation.
LOS expression undergoes phase variation at high frequencies (24) . We have observed that a pyocin-resistant derivative of 1291 (1291 d ) (4) that does not react with MAb 2-1-L8 and reacts poorly with MAb 1B2 shifts to reactivity with MAb 2-1-L8 with a corresponding loss of MAb 1B2 reactivity at a frequency of 1:3,000 (unpublished data). One of these LOS variants, RS132L, was examined by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE), and the shift in MAb binding specificity did not correspond to a change in the predominant LOS expressed by 1291 d , which is greatly truncated (rough). This suggested that the shift in MAb binding in 1291 d was the result of a change in the expression of a gene involved in regulating the expression of MAb 1B2-reactive LOS. This report describes experiments that we performed to help us understand the genetic basis of this phase shift.
Identification of a recombinant plasmid containing lsi-2 and SDS-PAGE analysis of transformants. Gonococcal LOS antigenic variation occurs at a high frequency (23). Since we previously showed that this variation had a genetic basis (the shift between expression of an LOS that reacts with MAb 1B2 and expression of an LOS that reacts with MAb2-1-L8 is mediated by lsi-2) (25), we designed experiments to clone the DNA responsible. Since a conventional strategy for identifying clones by isolating genes on plasmids and subsequently identifying the one able to alter LOS expression in the heterozygote would not work if the cloned gene encoded a defective or recessive gene, we designed a strategy that would allow us to screen genes directly in the gonococcus via allelic replacement. Neisserial chromosomal DNA was isolated by a modification of the method of Rodriguez and Tait (18) . This modification involved the use of proteinase K (50 g/ml) instead of pronase and subsequent incubation at 60ЊC. Chromosomal DNA from N. gonorrhoeae RS132L was digested with a variety of restriction enzymes, and the digested DNA was tested for its ability to alter the LOS phenotype of N. gonorrhoeae 1291 from reactivity with MAb 1B2 to reactivity with MAb 2-1-L8 (see Fig. 1 for LOS structure). The testing of DNA for the ability to transform N. gonorrhoeae was performed as follows. Serial dilutions of piliated gonococci were plated onto gonococcal medium base (Difco) with growth supplements (29a) GCK agar and allowed to air dry. Prewarmed DNA was suspended in water containing 10 mM MgCl 2 and spotted onto an agar plate. Cultures were incubated overnight, and isolated colonies that grew within the zone were tested for the ability to react with the appropriate MAb. Binding of MAbs for Western blot (immunoblot) analysis and for colony blotting of individual colonies was performed as described previously (21) . MAb 2-1-L8 (immunoglobulin G) and 19-1-L1 (immunoglobulin G) were generously provided by Wendell Zollinger, Walter Reed Army Institute of Research, Washington, D.C. MAb 1B2 (immuno-globulin M) was generously provided by J. McLeod Griffiss, University of California, San Francisco. DNA samples that retained their transforming ability after restriction enzyme digestion were size fractionated on a sucrose gradient, and fractions that possessed the ability to transform N. gonorrhoeae 1291 to reactivity with MAb 2-1-L8 were identified. These fractions were ligated into pUC19 (30) , and the recombinant plasmids were introduced into Escherichia coli DH5␣MCR by DNA transformation (19) . Colonies that contained recombinant plasmids (white colonies when grown in the presence of 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside [X-Gal]) were pooled together, and plasmid was isolated from these pools by the method of Birnboim and Doly (3). These plasmid pools were screened for the ability to transform N. gonorrhoeae 1291 to reactivity with MAb 2-1-L8. Subsequent rounds of screening eventually identified an individual plasmid, pREV1, that possessed this ability.
Plasmid pREV1 was used to transform N. gonorrhoeae 1291, and colonies were screened for the ability to react with MAb 2-1-L8. When DNA was added at saturating levels to piliated cells, approximately 25% of the colonies analyzed reacted with MAb 2-1-L8. In the absence of DNA, or when vector containing random fragments was used in these experiments, MAb 2-1-L8-reactive colonies were seen at the 1:3,000 reversion rate. Ten MAb 2-1-L8-reactive colonies were analyzed for reactivity with a variety of LOS-specific antibodies (MAb 1B2 detects the presence of the terminal Gal-GlcNAc, as seen in Fig. 1 , and MAb 17-1-L1 detects the addition of a Gal onto the 3.6-kDa LOS). All transformation-derived colonies had the same MAb reactivity profiles, i.e., they acquired the ability to react with MAb 2-1-L8 and lost the ability to react with MAb 1B2. In addition, their LOSs all displayed the same mobility when observed by SDS-PAGE. In contrast, when we examined spontaneous phase variants of 1291, similarly isolated on the basis of reactivity with MAb 2-1-L8, a variety of MAb reactivity profiles were seen, and multiple LOS bands were visualized by SDS-PAGE. These observations, in conjunction with the high transformation rate relative to the spontaneous-reversion rate, suggest that the transformants selected on the basis of their acquisition of MAb 2-1-L8 reactivity arose as the result of the transformation event and were not spontaneous phase variants.
In order to characterize the LOSs expressed by 1291 and its derivatives, SDS-PAGE profiles for proteinase K-treated whole-cell lysates were generated by the procedure of Hitchcock and Brown (11) . Approximately 1 g of purified LOS was subjected to SDS-PAGE on 13% acrylamide gels as described previously and was visualized by silver staining (21, 26) . The data in Fig. 1 demonstrate the mobilities on SDS-PAGE gels of LOSs of 1291-L8ϩ (a pREV1 transformant of strain 1291), 1291 c (a pyocin-resistant derivative of 1291), and 1291 (the parent strain). The structure of the predominant LOS expressed by strain 1291 (Fig. 1, lanes 3 ) has been determined, and the terminal four sugars are Gal-␤-1-4-GlcNac-␤-1-3-Gal-␤-1-4-Glc (12) . This LOS reacts with MAb 1B2 (data not shown) but fails to react with MAb 2-1-L8 (Fig. 1B) . The structure of the LOS made by strain 1291 c (Fig. 1, lanes 2 ) lacks the two terminal sugars seen in 1291 (deleted in Gal-␤-1-4-GlcNac-␤-1-3-linked sugars) (12) . This LOS reacts with MAb 2-1-L8 (Fig. 1B) but fails to react with MAb 1B2 (data not shown). The data in Fig. 1, lanes 1 , are for LOS isolated from N. gonorrhoeae 1291 after transformation with pREV1 (1291-L8ϩ). This LOS reacts with MAb 2-1-L8 (Fig. 1B) but fails to react with MAb 1B2 (data not shown). The structures of the LOSs isolated from 1291 and 1291 c and their binding to LOS-specific MAbs are shown in Fig. 1C .
From structural studies, we predicted that mutants derived from N. gonorrhoeae 1291 that react with MAb 2-1-L8 should be defective in either the ability to make N-acetylglucosamine or the ability to add this residue to a growing oligosaccharide. Figure 1B shows a Western blot of the gel in Fig. 1A reacted with MAb 2-1-L8. These data indicate that cells that incorporate the DNA contained in pREV1 express a single LOS that has the same apparent mobility and MAb reactivity as LOS from N. gonorrhoeae 1291 c . From these data, we concluded that the LOS made by N. gonorrhoeae 1291-L8ϩ has the same structure as LOS made by N. gonorrhoeae 1291 c .
Identification of the region responsible for the LOS phase shift. Plasmid pREV1 contained approximately 4.4 kb of gonococcal DNA. In order to localize the region on this plasmid responsible for the transformation event, unidirectional deletion derivatives were constructed by using an Erase-a-Base kit according to the manufacturer's instructions (Promega Biotech, Inc., Madison, Wis.). To ensure that the loss of transformability was due to the loss of the region of interest, and not due to the loss of a DNA sequence needed for efficient transformation of the gonococcus (7), the insert contained in pREV1 was subcloned into pK18UP, a derivative of pK18 that contains the gonococcal uptake sequence (making plasmid pREV2) (17, 20) . Various deletion derivatives of pREV2 were isolated and tested for the ability to alter LOS expression in N. gonorrhoeae 1291. The data in Fig. 2 indicate that the region responsible for the transforming ability was localized to approximately 300 bp of DNA. An additional clone lacking the DNA 3Ј of the localized region (pCLB1) was isolated by the same approach as that used to identify pREV1, and the clone was used to verify that DNA 3Ј of the localized region was not involved in the observed LOS variation. This clone maintained the ability to transform strain 1291 to reactivity with MAb 2-1-L8 (Fig. 2) . Analysis of the DNA sequence contained in pREV2. The DNA sequence of the insert contained in pREV2 was determined by the Sanger dideoxy method (22) by using the Sequenase version 2 sequencing kit (United States Biochemicals, Cleveland, Ohio) and ␣-35 S-dATP (New England Nuclear, DuPont, Boston, Mass.) and used to search computer databases by using the BLAST program (1). The insert found in pREV2 contains a gene, lsi-2, that is virtually identical to a gonococcal DNA sequence encoding a putative glycosyl transferase responsible for the addition of N-acetylglucosamine linked ␤-1-3 to galactose (lgtA) (8) .
There are six differences between the DNA sequences of lsi-2 and lgtA. Relative to the DNA sequence reported by Gotschlich (8) for lgtA, lsi-2 has a six-base deletion around the polyguanine [poly(G)] tract (GGGGGA). In addition, there are five point mutations distributed 3Ј to the poly(G) tract. Two of these are silent mutations, and one of them is conserved. Two of the mutations have the potential to alter the structure of the protein, as they involve changes in the charge density of the protein. The genes upstream of lsi-2 are highly homologous to glyS␣ and glyS␤ (the genes encoding the ␣ and ␤ subunits of glycyl-tRNA synthetase) (29) . These two open reading frames (ORFs) map outside of the region able to mediate the alteration of LOS expressed by N. gonorrhoeae 1291, and, because of the nature of their homologs, are unlikely to be directly involved in LOS biosynthesis. Downstream of lsi-2, an ORF that is virtually identical to lgtB (8) and shows 50% homology to lic2A, a gene involved in LOS biosynthesis in Haemophilus influenzae, was identified (10). This ORF, too, maps outside the region able to mediate transformation to MAb 2-1-L8 reactivity in N. gonorrhoeae 1291.
The DNA sequence of the region involved in phase variation contains a string of 13 guanine residues. These guanines are positioned in the DNA in such a way that the ORF encoding the glycosyl transferase (lsi-2) is disrupted, resulting in two overlapping ORFs. If the number of guanine residues in lsi-2 isolated from pREV2 were 12 or 15 instead of 13, the two ORFs would become fused, and this ORF would then encode a protein similar to LgtA. In addition, previous studies have shown that polymeric strings of guanine are involved in regulating the expression of pilC in N. gonorrhoeae, where the expression of the protein is regulated by a change in the number of guanine residues (13). We therefore wanted to determine if a change in the number of guanine residues is important in regulating the expression of lsi-2, as postulated by Gotschlich (8) .
If these two ORFs are part of a single, disrupted gene, whose expression is required to make a full-length LOS, the ORFs should be fused to produce a single functional gene in the parental strain, N. gonorrhoeae 1291 (MAb 1B2 reactive). The DNA sequence of this region was amplified from N. gonorrhoeae 1291 by PCR, and the DNA sequence of the amplicon was determined. We determined the DNA sequence of several PCR clones, as well as sequencing the PCR product directly. All of these analyses gave the same results. The data in Fig. 3 demonstrate that the DNA sequence in 1291 possesses 12 guanines, instead of 13. The net result of this 1-bp difference in N. gonorrhoeae 1291 is that lsi-2 encodes a nontruncated protein analogous to LgtA.
To further confirm that only the poly(G) tract is responsible for mediating the shift in LOS structure, the complete lsi-2 gene was cloned from strain 1291, and the DNA sequence of this clone was determined and compared with the sequence obtained for pREV2. The only difference was in the number of guanine residues in the poly(G) tract (data not shown). The number of guanines found in lsi-2 in an additional derivative of N. gonorrhoeae 1291, 1291 c , was determined. PCR analysis, as described above, indicated that strain 1291 c , which produces a single LOS of 3.6 kDa and reacts with MAb 2-1-L8, also contains 13 guanines (data not shown).
Determination of the expression state of lsi-2. The DNA contained in pREV2 was cloned from a derivative of strain 1291 (RS132L), whose largest LOS component is 3.6 kDa and reacts with MAb 2-1-L8. Since the strain that it was introduced into makes an LOS with an apparent mobility of 4.8 kDa, and the LOS of the transformant has an apparent mobility of 3.6 kDa (Fig. 1) , we hypothesized that the gene that we initially cloned is defective and that the alteration of mobility of LOS To verify that the altered phenotype is the result of a defective gene, a sequencespecific deletion was introduced into lsi-2 in N. gonorrhoeae 1291. A site-specific deletion was constructed by the Erasea-Base (Promega Biotech, Inc.) procedure to generate a bidirectional deletion within lsi-2. This procedure generated pREV2d, which contains a 653-bp deletion in the middle of lsi-2. Plasmid pREV2d was used to transform N. gonorrhoeae 1291. The data in Fig. 2 demonstrate that pREV2d is able to transform N. gonorrhoeae 1291 to reactivity with MAb 2-1-L8. Summary. We identified a recombinant plasmid, pREV2, that is able to alter the expression of LOS in N. gonorrhoeae 1291. Two ORFs contained on pREV2 have significant homology with genes involved in LOS or lipopolysaccharide biosynthesis in a variety of organisms (16, 31) . One of these ORFs has been predicted to be involved in the addition of galactose to N-acetylglucosamine in N. gonorrhoeae (lgtB) (8) . The ORF identified as lsi-2 is virtually identical to lgtA from N. gonorrhoeae F62 (8) .
The region responsible for the alteration of LOS expression in N. gonorrhoeae 1291 was mapped to lsi-2, which contains two ORFs instead of the expected single ORF encoding a protein similar to lgtA. Analysis of the DNA sequence indicated that these two ORFs overlap and that each contains a string of guanines. When the DNA sequence of this region was amplified from N. gonorrhoeae 1291 by PCR and the DNA sequence of the amplicon was determined, this region was found to contain 12 guanines. This differed from the DNA sequence found in pREV2, which has 13 guanines. Since the DNA contained in pREV2 was cloned from a strain that expresses a truncated LOS, we hypothesized that the alteration in LOS expression seen in transformants of N. gonorrhoeae 1291 is due to the incorporation of a frameshift caused by the addition of a guanine in the coding sequence, resulting in a defective gene. We tested this hypothesis by constructing a site-specific deletion in lsi-2 and introducing this deletion into the chromosome of N. gonorrhoeae 1291. Since transformants that incorporated this deletion produce a truncated LOS, we concluded that the gene contained on pREV2 is defective.
The data described above indicate that in strains expressing an LOS that reacts with MAb 1B2, the lsi-2 gene product must be functional. Variants that produce a truncated LOS are the result of a change in the number of guanines. The ability of the gonococcus to change the number of guanines in lsi-2 would provide a mechanism that would allow for a rapid change in the LOS phenotype expressed by a cell.
Since the region downstream of lsi-2 contains several additional genes involved in LOS biosynthesis (reference 8 and data not shown), the presence of a polyguanine tract in lsi-2 implies that the addition of N-acetylglucosamine, the sugar added by Lsi2, is important to the overall regulation of the type of LOS that is expressed on the surface of the gonococcus. We believe that the structure of the LOS that reacts with MAb 2-1-L8 is a gonococcal core structure. Additions to this core are regulated by ability of the gonococcus to make a functional lsi-2 gene product which is modulated by a poly(G) tract within the gene.
Nucleotide sequence accession number. The DNA sequence of the relevant region of pREV1 has been submitted to GenBank and has the accession number U15992.
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